Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 32Terminated 7Active not recruiting 6Recruiting 5Withdrawn 4Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Myelodysplastic Syndromes 4Lymphoma, Non-Hodgkin 2Lymphoma 2Leukemia 2Hodgkin Disease 2Neoplasm, Residual 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Myeloid, Acute 1Leukemia, Myeloid, Accelerated Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia, Biphenotypic, Acute 1Hematologic Neoplasms 1Graft vs Host Disease 1

Interventions

Peripheral Blood Stem Cell Transplantation 3fludarabine phosphate 2Polymerase Chain Reaction 2Cyclophosphamide 2Antilymphocyte Serum 2treosulfan 1thymoglobulin 1sargramostim 1eprenetapopt 1Whole-Body Irradiation 1Tacrolimus 1Standard of Care 1Pharmacogenomic Testing 1Mycophenolic Acid 1Methotrexate 1Mercaptopurine 1Ketamine 1Immunoenzyme Techniques 1Flow Cytometry 1Filgrastim 1Decitabine 1Cytarabine 1Cord Blood Stem Cell Transplantation 1Carboplatin 1Busulfan 1Bronchoscopy 1Bronchoalveolar Lavage 1Blood Specimen Collection 1Biopsy 1Base Sequence 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Myeloproliferative Disorders × Whole-Body Irradiation × Clear all
NCT01894477 2021-06-03

Treo/Flu/TBI With Donor Stem Cell Transplant for Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia

Fred Hutchinson Cancer Center

Phase 2 Unknown
102 enrolled 12 charts
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myelomonocytic, Chronic, Neoplasm, Residual, Myelodysplastic-Myeloproliferative Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡